CorriXR Therapeutics
CorriXR Therapeutics is a startup headquartered in Newark, United States, founded in 2022. It has raised at least $6.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
CorriXR Therapeutics has raised at least $6.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
CorriXR Therapeutics sits inside the Philadelphia region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Newark
- AAA Advantage Home Care
- Algoma
- Atomic Technologies
- Audience Town
- Avallon Labs
- D5Cash
- Detection Innovation Group
- Divacs
- Earlyasset
- Eduvue
- Farworld Labs
Related
- Innovation profile of Newark
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does CorriXR Therapeutics do?
CorriXR Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has CorriXR Therapeutics raised?
At least $6.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is CorriXR Therapeutics based?
CorriXR Therapeutics is headquartered in Newark, United States.
When was CorriXR Therapeutics founded?
CorriXR Therapeutics was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.